Gene therapy’s breakout moment

March SyringeWithDNA GeneTherapyWilsonBioP e
Credit: Mopic - via GEN

The following is an excerpt.

Venture capital interest in funding gene therapies and the companies that develop them has dramatically increased judging by a recent spurt of activity, a lot of due diligence, a few deals announced, and a few more in the works and expected to be announced soon.

What does all that activity mean? First, there’s enough clinical data out there to validate the concept of gene therapy. The more speculative venture capital investors, rather than the pharmaceutical industry, are realizing the potential of this and are getting into the game.

View the original article here: Is This Gene Therapy’s Breakout Moment?

Additional resources:

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend